Adrian Adams | Chairman & Chief Executive Officer |
Leonard Paolillo | Chief Commercial Officer |
Rajiv Amin | Controller & Interim Chief Financial Officer |
Stacy Ku | Cowen |
Eddie Hickman | Guggenheim Partners |
Laura Chico | Wedbush |
Sean Kim | JonesTrading |
Good morning, ladies and gentlemen and welcome to Impel Pharmaceuticals Fourth Quarter and Full Year 2022 Earnings and Business Update Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded.
I would now like to turn the conference over to Impel's Chairman and Chief Executive Officer, Mr. Adrian Adams. Please go ahead, sir.